US Broker Ratings

Innoviva, Inc. (INVA) Stock Analysis: Exploring a 180.9% Potential Upside in the Biotech Sector

Innoviva, Inc. (NASDAQ: INVA), a biotechnology company with a market capitalization of $1.23 billion, is making waves in the healthcare sector with its promising portfolio of..

MiMedx Group, Inc. (MDXG) Stock Analysis: Potential 76% Upside and Strong Buy Ratings Signal Growth Opportunities

Investors often seek transformative opportunities in the biotechnology sector, and MiMedx Group, Inc. (NASDAQ: MDXG) presents an intriguing case with its promising potential upside of 76.47%..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Uncovering a 24.51% Upside Potential

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a prominent player in the healthcare sector, specializing in the development and commercialization of both branded and generic pharmaceutical products, presents..

Vera Therapeutics, Inc. (VERA) Stock Report: Unlocking a Potential Upside of 166.43% in the Biotechnology Arena

Vera Therapeutics, Inc. (NASDAQ: VERA), a burgeoning name in the biotechnology sector, is capturing the attention of investors with its innovative approach to addressing serious immunological..

Enovis Corporation (ENOV) Stock Analysis: Unveiling a 76.78% Potential Upside in the Medical Devices Sector

Enovis Corporation (NYSE: ENOV) stands at a pivotal juncture for investors eyeing the healthcare sector, particularly its niche in medical devices. With a market capitalization of..

Omnicell, Inc. (OMCL) Investor Outlook: Navigating a 44% Potential Upside Amidst Healthcare Innovations

Omnicell, Inc. (OMCL) stands as a notable player in the healthcare sector, specializing in health information services. With a market capitalization of $1.29 billion, Omnicell is..

Addus HomeCare Corporation (ADUS) Stock Analysis: Promising 22% Upside Potential

Addus HomeCare Corporation (NASDAQ: ADUS), a prominent player in the healthcare sector, specializes in providing essential personal care services to a diverse clientele, including the elderly..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Analyzing A Promising 93.45% Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a biotechnology leader specializing in rare disease therapeutics, has captured the attention of investors with its significant growth potential. With a..

10x Genomics, Inc. (TXG): An Investor Outlook on Its 4.87% Potential Upside

10x Genomics, Inc. (NASDAQ: TXG), a key player in the health information services industry, has been capturing attention with its cutting-edge life science technology solutions. Based..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Exploring a 41.79% Potential Upside in the Booming CGT Market

BioLife Solutions, Inc. (BLFS) has emerged as a pivotal player in the burgeoning cell and gene therapy (CGT) industry. With its headquarters in Bothell, Washington, this..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a Potential 116.71% Upside in the Biopharmaceutical Sector

Dynavax Technologies Corporation (NASDAQ: DVAX), a prominent player in the healthcare sector, has piqued the interest of investors with its substantial potential upside of 116.71%. This..

Amphastar Pharmaceuticals, Inc. (AMPH): Investor Outlook Reveals 47.61% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector, specializes in the development and manufacturing of generic and proprietary injectable, inhalation, and intranasal..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 63% Upside Potential in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a significant player in the healthcare sector, is captivating investor attention with its potential upside of 63.35%. Specializing in diagnostic testing solutions,..

Schrodinger, Inc. (SDGR) Investor Outlook: Exploring the 50% Upside Potential Amid Rapid Revenue Growth

Schrodinger, Inc. (SDGR), a key player in the healthcare sector, is making waves with its innovative approach to drug discovery and molecular development. Based in New..

LivaNova PLC (LIVN) Stock Analysis: Exploring a 38.8% Potential Upside in the Medical Device Market

LivaNova PLC (NASDAQ: LIVN), a leading medical technology company headquartered in London, UK, is capturing the attention of investors with its promising growth prospects in the..

AtriCure, Inc. (ATRC) Stock Analysis: Unveiling a 59% Potential Upside with Strong Buy Ratings

AtriCure, Inc. (NASDAQ: ATRC) presents an intriguing opportunity for investors looking at the healthcare sector, particularly in the niche of medical instruments and supplies. With a..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 26.63% Potential Upside in the Healthcare Sector

UFP Technologies, Inc. (NASDAQ: UFPT), a key player in the healthcare sector specializing in medical devices, is currently catching the eye of investors with its potential..

GoodRx Holdings, Inc. (GDRX) Investor Outlook: Exploring a 30.78% Potential Upside in Health Information Services

GoodRx Holdings, Inc. (NASDAQ: GDRX), a prominent player in the healthcare sector, offers a unique proposition for investors seeking exposure to health information services. With a..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 133% Potential Upside in the Biotech Sector

Immunovant, Inc. (NASDAQ: IMVT) has carved out a niche within the biotechnology sector, focusing on the development of monoclonal antibodies for autoimmune diseases. Its clinical-stage status..

Mesoblast Limited (MESO) Stock Analysis: A Biotech Play with 141% Potential Upside

Mesoblast Limited (NASDAQ: MESO), an Australia-based biotechnology company, is capturing investor attention with its innovative approach to regenerative medicine. Focused on developing therapies for inflammatory diseases..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds